To date, AFP is the only serum biomarker available for HB diagnosis given its elevation in approximately 90% of patients7; however, serum AFP level is also high in healthy infants and cannot distinguish HB from benign liver tumours and hepatocellular carcinoma (HCC).8, 9. This evidence concerns the gene AFP and hepatocellular carcinoma.